MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 215 filers reported holding MIRATI THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.31 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $66,552,187 | +1388.1% | 1,527,828 | +1134.3% | 0.01% | – |
| Q2 2023 | $4,472,290 | -66.2% | 123,783 | -65.2% | 0.00% | -100.0% |
| Q1 2023 | $13,242,276 | -57.4% | 356,166 | -48.1% | 0.00% | -66.7% |
| Q4 2022 | $31,083,928 | -79.2% | 686,028 | -68.0% | 0.00% | -81.2% |
| Q3 2022 | $149,502,000 | +10.9% | 2,140,622 | +6.6% | 0.02% | +23.1% |
| Q2 2022 | $134,761,000 | -30.1% | 2,007,464 | -14.4% | 0.01% | -13.3% |
| Q1 2022 | $192,852,000 | -51.9% | 2,345,577 | -14.3% | 0.02% | -50.0% |
| Q4 2021 | $401,315,000 | -14.4% | 2,735,803 | +3.2% | 0.03% | -18.9% |
| Q3 2021 | $468,858,000 | +9.1% | 2,650,261 | -0.4% | 0.04% | +8.8% |
| Q2 2021 | $429,755,000 | -9.9% | 2,660,526 | -4.4% | 0.03% | -17.1% |
| Q1 2021 | $476,817,000 | -21.9% | 2,783,524 | +0.2% | 0.04% | -24.1% |
| Q4 2020 | $610,239,000 | +47.9% | 2,778,358 | +11.8% | 0.05% | +28.6% |
| Q3 2020 | $412,734,000 | +74.6% | 2,485,602 | +20.0% | 0.04% | +61.5% |
| Q2 2020 | $236,391,000 | +10.9% | 2,070,525 | -25.3% | 0.03% | -13.3% |
| Q1 2020 | $213,139,000 | -17.9% | 2,772,713 | +37.5% | 0.03% | +3.4% |
| Q4 2019 | $259,759,000 | +52.3% | 2,015,821 | -7.9% | 0.03% | +45.0% |
| Q3 2019 | $170,582,000 | -43.5% | 2,189,473 | -25.2% | 0.02% | -42.9% |
| Q2 2019 | $301,680,000 | -10.7% | 2,928,931 | -36.4% | 0.04% | -12.5% |
| Q1 2019 | $337,640,000 | +262.4% | 4,606,270 | +109.7% | 0.04% | +207.7% |
| Q4 2018 | $93,171,000 | -7.2% | 2,196,388 | +3.0% | 0.01% | +18.2% |
| Q3 2018 | $100,450,000 | +2.6% | 2,132,689 | +7.4% | 0.01% | 0.0% |
| Q2 2018 | $97,926,000 | +168.9% | 1,986,315 | +67.5% | 0.01% | +175.0% |
| Q1 2018 | $36,413,000 | +318.6% | 1,186,092 | -25.5% | 0.00% | +300.0% |
| Q2 2016 | $8,698,000 | -84.4% | 1,593,092 | -39.0% | 0.00% | -87.5% |
| Q1 2016 | $55,889,000 | -38.8% | 2,611,629 | -9.6% | 0.01% | -33.3% |
| Q4 2015 | $91,320,000 | -4.9% | 2,889,888 | +3.6% | 0.01% | -14.3% |
| Q3 2015 | $96,021,000 | +25.9% | 2,789,688 | +15.1% | 0.01% | +40.0% |
| Q2 2015 | $76,286,000 | +7.3% | 2,424,075 | 0.0% | 0.01% | +11.1% |
| Q1 2015 | $71,074,000 | +192.6% | 2,424,075 | +84.8% | 0.01% | +200.0% |
| Q4 2014 | $24,291,000 | +11.5% | 1,311,623 | +5.4% | 0.00% | 0.0% |
| Q3 2014 | $21,787,000 | -10.3% | 1,244,275 | +2.5% | 0.00% | 0.0% |
| Q2 2014 | $24,286,000 | -11.2% | 1,214,275 | -15.3% | 0.00% | -25.0% |
| Q1 2014 | $27,351,000 | +124.9% | 1,434,261 | +96.1% | 0.00% | +100.0% |
| Q4 2013 | $12,161,000 | – | 731,275 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $136,602,679 | 87.83% |
| EcoR1 Capital, LLC | 5,748,399 | $250,400,260 | 8.45% |
| Boxer Capital, LLC | 3,201,440 | $139,454,726 | 7.42% |
| RTW INVESTMENTS, LP | 6,768,514 | $294,836,470 | 6.22% |
| Paradigm Biocapital Advisors LP | 1,668,116 | $72,663,133 | 4.93% |
| Avoro Capital Advisors LLC | 6,666,666 | $290,399,971 | 4.53% |
| Octagon Capital Advisors LP | 655,051 | $28,534,022 | 4.38% |
| Artal Group S.A. | 2,024,226 | $88,175 | 3.78% |
| Ally Bridge Group (NY) LLC | 70,283 | $3,061,527 | 3.59% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $9,404,640 | 3.17% |